Skip to main content
. 2017 Dec 19;2(1):6–12. doi: 10.1002/ags3.12047

Table 3.

Adjuvant chemotherapy regimens by region

JSCCR NCCN ESMO
UFT+LV FOLFOX FOLFOX
Cape CapeOX CapeOX
S‐1 FLOX Cape
5‐FU+l‐LV Cape 5‐FU+l‐LV
FOLFOX 5‐FU+l‐LV
CapeOX

Cape, capecitabine; CapeOX, capecitabine+oxaliplatin; ESMO, European Society for Medical Oncology; FLOX, infusional fluorouracil+l‐leucovorin (weekly)+oxaliplatin (biweekly); FOLFOX, infusional fluorouracil+l‐leucovorin+oxaliplatin; 5‐FU+l‐LV, fluorouracil+l‐leucovorin; JSCCR, Japanese Society for Cancer of the Colon and Rectum; NCCN, National Comprehensive Cancer Network; S‐1, tegafur‐gimeracil‐oteracil potassium; UFT+LV, tegafur‐uracil+leucovorin.